HH
TGTX icon

HWG Holdings’s TG Therapeutics TGTX Stock Holding History

HWG Holdings’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,132
Closed -$12.9K – 116
2017
Q2 		$11K Sell
1,132
-23,024
-95% -$258K 0.01% 67
2017
Q1 		$281K Buy
+24,156
New +$173K 0.35% 29
2015
Q2 		– Sell
-112,520
Closed -$1.74M – 30
2015
Q1 		$1.74M Sell
112,520
-256,953
-70% -$3.89M 2.81% 12
2014
Q4 		$5.85M Buy
+369,473
New +$4.81M 4.17% 6

Other funds holding TGTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

HWG Holdings's TGTX Position: Q3 2017 in Review

HWG Holdings sold out of TG Therapeutics (TGTX) in Q3 2017, closing a stake of 1,132 shares — an estimated $12.9K sold.

HWG Holdings first reported a position in TGTX in Q4 2014 and held it in 4 quarters. The position peaked at $5.85M in Q4 2014. 101 funds tracked by Wall St. Rank hold TGTX as of Q3 2017.

  • HWG Holdings reported no remaining TG Therapeutics position as of Q3 2017 after selling out during the quarter.
  • HWG Holdings sold 1,132 TG Therapeutics shares in Q3 2017, an estimated $12.9K.
  • HWG Holdings first reported a position in TG Therapeutics in Q4 2014 and held it in 4 quarters.
  • HWG Holdings's TG Therapeutics position peaked at $5.85M in Q4 2014.
  • 101 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2017.

Based on HWG Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.